SG Americas Securities
SANA icon

SG Americas Securities’s Sana Biotechnology SANA Stock Holding History

SG Americas Securities’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$332K Sell
95,039
-35,044
-27% -$113K ﹤0.01% 2534
2026
Q1 		$375K Buy
130,083
+31,796
+32% +$125K ﹤0.01% 2337
2025
Q4 		$400K Sell
98,287
-1,971
-2% -$8.83K ﹤0.01% 2613
2025
Q3 		$356K Buy
100,258
+17,581
+21% +$63.6K ﹤0.01% 2372
2025
Q2 		$226K Sell
82,677
-33,830
-29% -$69.8K ﹤0.01% 2190
2025
Q1 		$196K Sell
116,507
-29,984
-20% -$83.8K ﹤0.01% 2546
2024
Q4 		$239K Buy
+146,491
New +$437K ﹤0.01% 1986
2024
Q2 		– Sell
-11,513
Closed -$115K – 3256
2024
Q1 		$115K Sell
11,513
-12,857
-53% -$96.3K ﹤0.01% 2449
2023
Q4 		$99K Buy
+24,370
New +$89.8K ﹤0.01% 2772
2022
Q3 		– Sell
-118,044
Closed -$759K – 3508
2022
Q2 		$759K Buy
118,044
+89,323
+311% +$569K 0.01% 1565
2022
Q1 		$237K Buy
28,721
+9,559
+50% +$77.3K ﹤0.01% 2329
2021
Q4 		$297K Sell
19,162
-15,365
-45% -$296K ﹤0.01% 2446
2021
Q3 		$778K Buy
34,527
+19,302
+127% +$405K ﹤0.01% 2120
2021
Q2 		$299K Buy
15,225
+8,645
+131% +$196K ﹤0.01% 2169
2021
Q1 		$220K Buy
+6,580
New +$214K ﹤0.01% 2620

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

SG Americas Securities's SANA Position: Q2 2026 in Review

SG Americas Securities reduced its Sana Biotechnology (SANA) stake by 27% in Q2 2026, selling an estimated $113K and leaving 95,039 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

SG Americas Securities first reported a position in SANA in Q1 2021 and has held it in 15 quarters since. The position peaked at $778K in Q3 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • SG Americas Securities held 95,039 shares of Sana Biotechnology worth $332K as of Q2 2026.
  • SG Americas Securities sold 35,044 Sana Biotechnology shares in Q2 2026, an estimated $113K.
  • Sana Biotechnology made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2534 holding.
  • SG Americas Securities first reported a position in Sana Biotechnology in Q1 2021 and has held it in 15 quarters since.
  • SG Americas Securities's Sana Biotechnology position peaked at $778K in Q3 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.